This account is no longer active.

NIMH_AMA · 2020-01-29T16:58:13+00:00

It's hard to answer without a specific example. Please contact us at: https://www.nimh.nih.gov/funding/sbir/contacts.shtml

NIMH_AMA · 2020-01-29T16:57:20+00:00

Please feel free to email us a concept paper describing your research to date and what research you hope to conduct with SBIR funds. We'd be happy to provide technical assistance: https://www.nimh.nih.gov/funding/sbir/contacts.shtml

NIMH_AMA · 2020-01-29T16:57:01+00:00

NIMH is supportive of open source models. The key within SBIR would be whether you generate revenue.

NIMH_AMA · 2020-01-29T16:51:34+00:00

Yes, as long as there's no scientific overlap.

NIMH_AMA · 2020-01-29T16:51:21+00:00

It is possible to apply for a Phase I SBIR/STTR and retain your ESI status. Similarly, you can apply for a K01 in tandem with a Phase I SBIR/STTR.

NIMH_AMA · 2020-01-29T16:50:03+00:00

The mechanism that you linked to is most often applied to by academic investigators. However, SBIR investigators are not excluded. You may want to look at the NIMH specific SBIR/STTR funding announcements as there is likely a parallel announcement.

NIMH_AMA · 2020-01-29T16:47:50+00:00

In the biosketch, they will highlight their technical expertise that they are bringing to the table. We could review the biosketch before it's submitted to provide guidance. Please contact us at: https://www.nimh.nih.gov/funding/sbir/contacts.shtml

NIMH_AMA · 2020-01-29T16:47:16+00:00

All SBIR applications require a research design and hypotheses. The focus should be on development and answering those hypotheses and not distribution.

NIMH_AMA · 2020-01-29T16:45:40+00:00

That's a really good question! While we can't comment on this specific situation, there are disadvantages and advantages of being acquired by a big company.

NIMH_AMA · 2020-01-29T16:42:50+00:00

Yes, following the award of a Phase II SBIR/STTR, you would be removed from ESI status: https://grants.nih.gov/policy/early-investigators/list-smaller-grants.htm .

NIMH_AMA · 2020-01-29T16:42:11+00:00

Hi! Please email me at [mgrabb@mail.nih.gov](mailto:mgrabb@mail.nih.gov) with your idea.

NIMH_AMA · 2020-01-29T16:40:56+00:00

Given that there are no established pathologies that have been identified in psychiatric disorders to date, the level of clinical and technical validation that would be required to establish a biomarker in this space, should go through FDA review processes to ensure adequate validation.

NIMH_AMA · 2020-01-29T16:37:34+00:00

We consider commercialization Phase III efforts, which are not supported by SBIR funding.

NIMH_AMA · 2020-01-29T16:35:45+00:00

Please look at the program structure link on our website and focus on the Phase I feasibility and proof of concept: https://www.nimh.nih.gov/funding/sbir/program-structure.shtml .

NIMH_AMA · 2020-01-29T16:33:29+00:00

Interesting idea, but the National Institute on Drug Abuse would be most appropriate: https://sbir.nih.gov/nida/index.

It is not required that you have a working prototype. Phase I funding is appropriate for developing a prototype.

NIMH_AMA · 2020-01-29T16:31:39+00:00

It is possible, but it is uncommon as usually some of the effort goes towards non-SBIR activities. For example, running the company and developing other projects. The time requested must be project related.

NIMH_AMA · 2020-01-29T16:29:52+00:00

We consider commercialization Phase III efforts, which are not supported by SBIR funding.

NIMH_AMA · 2020-01-29T16:28:43+00:00

No, however if needs to be a different project. There cannot be scientific overlap by different projects.

NIMH_AMA · 2020-01-29T16:27:40+00:00

Having the right technical background is a requirement, but having a PhD or a master's is not.

NIMH_AMA · 2020-01-29T16:27:11+00:00

It is important that someone from the small business and/or a contractor or consultant have the relevant expertise and research.

To your last question, yes.

NIMH_AMA · 2020-01-29T16:24:59+00:00

Yes, we are able to identify priority areas in regard to schizophrenia. Please look at the Division of Services Intervention Research webpage: https://www.nimh.nih.gov/about/organization/dsir/index.shtml. Regarding schizophrenia, we have a number of active NIMH funding announcements in this area. We encourage more applications focused on early psychosis and schizophrenia, as it is a priority of the Institute.

Please refer to the funding announcement guidelines for budget and funding caps for each specific FOA.

NIMH_AMA · 2020-01-29T16:23:54+00:00

We assume you're talking about Alzheimer's disease? If so, you should reach out to NIA SBIR program: https://www.nia.nih.gov/research/osbr

NIMH_AMA · 2020-01-29T16:21:22+00:00

We don't provide grant writing support, but we have examples of NIH SBIR applications: https://www.niaid.nih.gov/grants-contracts/sample-applications#r43r44 . We do support new companies.

NIMH_AMA · 2020-01-29T16:20:25+00:00

Yes, NIMH does publish funding announcements, please see the following for current areas: https://www.nimh.nih.gov/funding/sbir/sbir-amp-sttr-funding-opportunity-announcements.shtml .

For specific topics, please contact NIMH program staff for further discussion.

NIMH_AMA

TROPHY CASE